Skip to content
Disclosery

Deer VI & Co. LLC

Follow

13F filer, CIK 1362890, Larchmont, NY

Deer VI & Co. LLC reported $2,235,000 across 1 holding for the quarter ended 2018-09-30, in a 13F-HR filed 2018-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-18-011983

Period
2018-09-30
Reported value
$2.23M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2018

Share positions as resolved from 13F-HR 0000950123-18-011983, largest first. % of portfolio is the value over $2,235,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AVEO PHARMACEUTICALS INCAVEO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: 675,242 shares; 2017Q1: 675,242 shares; 2017Q2: 675,242 shares; 2017Q3: 675,242 shares; 2017Q4: 675,242 shares; 2018Q1: 675,242 shares; 2018Q2: 675,242 shares; 2018Q3: 675,242 shares 675,242$2.23M100%0

How Q3 2018 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-18-011983 base2018-11-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000950123-18-011983 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0000950123-18-008934 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0000950123-18-005776 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0000950123-18-002452 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0000950123-17-010971 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0000950123-17-008019 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR/A 0000950123-17-005474 Quarter ended 2017-03-312017-05-22acceptance time not in the bulk data set
13F-HR 0000950123-17-005229 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0000950123-17-002385 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0000950123-16-021934 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0000950123-16-019759 Quarter ended 2016-06-302016-08-12acceptance time not in the bulk data set
13F-HR 0000950123-16-017157 Quarter ended 2016-03-312016-05-13acceptance time not in the bulk data set
13F-HR 0000950123-16-014853 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR 0000950123-15-011946 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0000950123-15-008972 Quarter ended 2015-06-302015-08-13acceptance time not in the bulk data set
13F-HR 0000950123-15-006033 Quarter ended 2015-03-312015-05-14acceptance time not in the bulk data set
13F-HR 0000950123-15-002158 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set
13F-HR 0000950123-14-011763 Quarter ended 2014-09-302014-11-13acceptance time not in the bulk data set
13F-HR 0000950123-14-007710 Quarter ended 2014-06-302014-08-04acceptance time not in the bulk data set
13F-HR 0000950123-14-005457 Quarter ended 2014-03-312014-05-12acceptance time not in the bulk data set
13F-HR 0000950123-14-001331 Quarter ended 2013-12-312014-02-07acceptance time not in the bulk data set
13F-HR 0000950123-13-009588 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0000950123-13-006871 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set